Taiwanese Journal of Obstetrics and Gynecology
Volume 45, Issue 3 , Pages 225-229, September 2006

Pilot Study of Labor Induction with Titrated oral Misoprostol

  • Shi-Yann Cheng

      Affiliations

    • Corresponding Author InformationCorrespondence to: Dr Shi-Yann Cheng, Department of Obstetrics and Gynecology, China Medical University Peikang Hospital, 123, Shin Der Road, Peikang, Yun Lin 651, Taiwan
  • ,
  • Tai-Chang Chen

Department of Obstetrics and Gynecology, China Medical University Peikang Hospital, Yun Lin, Taiwan

Accepted 24 May 2006.

Article Outline

Summary 

Objective

To evaluate the safety and efficacy of titrated oral misoprostol for labor induction at term.

Materials and Methods

Seventy-seven pregnant women (37 nullipara and 40 multipara), with medical or obstetric indications for labor induction after 37 weeks of gestation and unfavorable cervices (Bishop's score < 7), were induced according to the principles of titrated oral doses of misoprostol against uterine response. Our primary outcome measurements were the percentage of patients who had a vaginal delivery within 24 hours of induction and the interval from induction to vaginal delivery. Secondary measurements included oxytocin requirement, total misoprostol dosage, number of cesarean deliveries, induction failure, uterine hyper-stimulation rates and neonatal outcomes.

Results

Seventy-five women (97.4%) experienced active labor within 24 hours, with 72 (93.5%) completing vaginal delivery within 24 hours. The mean interval from induction to vaginal delivery for all the women was 9.7 hours, with a 2.3-hour active phase. The mean misoprostol dosage was 206 mg, with eight women (10.4%) requiring oxytocin augmentation. There was no uterine hyperstimulation or induction failure, except for seven cases of uterine tachysystole (9.1%).

Conclusion

Titrated oral misoprostol is a safe and effective method of labor induction because the dosage can be adjusted according to individual response.

Key Words:  cervical ripening , labor induction , misoprostol

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Committee on Obstetrics  . Induction of Labor . ACOG Technical Bulletin No. 217 . Washington: American College of Obstetricians and Gynecologists; 1995;
  2. Margulies M , Campos Perez G , Voto LS . Misoprostol to induce labour . Lancet . 1992;339:64; [Letter]
  3. Sanchez-Ramos L , Kaunitz AM , Del Valle GO , Delke I , Schroeder PA , Briones DK . Labor induction with prostaglandin E1 methyl analogue misoprostol versus oxytocin: a randomized trial . Obstet Gynecol . 1993;81:332–336
  4. Hofmeyr GJ , Gulmezoglu AM , Alfirevic Z . Misoprostol for the induction of labour: a systemic review . Br J Obstet Gynecol . 1999;106:798–803
  5. Wing DA . Labor induction with misoprostol . Am J Obstet Gynecol . 1999;180:339–344
  6. Keirse MJNC . Prostaglandins in preinduction cervical ripening: meta-analysis of worldwide clinical experience . J Reprod Med . 1993;38:89–98
  7. Hofmeyr GJ , Gulmezoglu AM . Vaginal misoprostol for cervical ripening and labour induction in late pregnancy (Cochrane review) . The Cochrane Library, Issue 2 . Oxford: Update Software; 2001;
  8. Alfirevic Z , Howarth G , Gausmann A . Oral misoprostol for induction of labour with a viable fetus (Cochrane review) . The Cochrane Library, Issue 2 . Oxford: Update Software; 2001;
  9. Bennett KA , Butt K , Grane JMG , Hutchens D , Young DC . A masked randomized comparison of oral and vaginal administration of misoprostol for labor induction . Obstet Gynecol . 1998;92:481–486
  10. Wing DA , Ham D , Paul RH . A comparison of orally administered misoprostol with vaginally administered misoprostol for cervical ripening and labor induction . Am J Obstet Gynecol . 1999;180:1155–1160
  11. Wing DA , Park MR , Paul RH . A randomized comparison of oral and intravaginal misoprostol for labor induction . Obstet Gynecol . 2000;95:905–908
  12. Shetty A , Martin R , Danielian P , Templeton A . A comparison of two dosage regimens of oral misoprostol for labor induction at term . Acta Obstet Gynecol Scand . 2002;81:337–342
  13. Kolderup L , Mclean L , Grullon K , Safford RN , Kilpatrick SJ . Misoprostol is more efficacious for labor induction than prostaglandin E2, but is it associated with more risk? . Am J Obstet Gynecol . 1999;180:1543–1547
  14. Shetty A , Danielian P , Templeton A . A comparison of oral and vaginal misoprostol tablets in the induction of labor at term . Br J Obstet Gynaecol . 2001;108:1–6
  15. Shetty A , Mackie L , Danielian P , Rice P , Templeton A . Sublingual compared with oral misoprostol in term labour induction: a randomized controlled trial . Br J Obstet Gynecol . 2002;109:645–650
  16. Zeiman M , Fong SK , Benowitz NL , Bankster D , Darney PD . Absorption kinetics of misoprostol with oral or vaginal administration . Obstet Gynecol . 1997;90:88–92
  17. Daneilsson GK , Marions L , Rodriguez A , Spur BW , Wong PYK , Bygdeman M . Comparison between oral and vaginal administration of misoprostol on uterine contractility . Obstet Gynecol . 1999;93:275–280
  18. Hofmeyr GJ , Matonhodze BB , Alfirevic Z , et al.   Titrated oral misoprostol solution-a new method of labour induction . S Afr Med J . 2001;91:775–776
  19. Cheng SY . Labor induction using titrated oral doses of misoprostol in pregnancy with myoma . Taiwanese J Obstet Gynecol . 2003;42:147–151
  20. Kilpatrich SJ , Laros RK . Characteristics of normal labor . Obstet Gynecol . 1989;74:81–87
  21. Albers LL , Schiff M , Gorwoda JG . The length of active labor in normal pregnancy . Obstet Gynecol . 1996;87:355–359
  22. Chong YS , Chua S , Shen L , Arulkumaran S . Does the route of administration of misoprostol make a difference? The uterotonic effect and side effects of misoprostol given by different routes after vaginal delivery . Eur J Obstet Gynecol Reprod Biol . 2004;113:191–198

PII: S1028-4559(09)60229-1

doi:10.1016/S1028-4559(09)60229-1

Taiwanese Journal of Obstetrics and Gynecology
Volume 45, Issue 3 , Pages 225-229, September 2006